Metabolic disorders Flashcards

1
Q

Case
CC: Poor weight Gain
K.A. 3mo/F , sees you for the first time with the chief complaint of
poor weight gain.
Pertinent in the birth history is history of
(+) feeding difficulties with frequent vomiting episodes
(+) prolonged jaundice
(+) poor weight gain
(+) history of seizures
Newborn screening: (+)
Nutritional History: Exclusively breastfed
PE:
Weight for age below -3 , Length for age below -3
lethargic , generalized hypotonia, (+) jaundice
(+) bilateral cataracts
(+) hepatomegaly
(+) splenomegaly
Laboratory:
CBC: WBC 9.0 Hgb 145 Hct .45 plt
Blood CS: NG5D
RBS: low
ABG: metabolic acidosis
Babygram: Normal chest, hepatomegaly, paucity of bowel pattern

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary impression?

A

Galactosemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the basis for the primary impression?

A

Basis:
Typical signs and Symptoms at Birth/ Hx
o feeding difficulties with frequent vomiting episodes
o prolonged jaundice
o poor weight gain
o history of seizures
o Newborn screening: (+)
Physical findings
o Poor growth within the first few weeks of life
o Jaundice
o Bleeding from coagulopathy
o Liver dysfunction and/or hepatomegaly
o Cataracts (sometimes as early as the first few days of
life)
o Lethargy
o Hypotonia
o Sepsis (E coli)
Lab Results:
o NBS (+) Galactosemia
o RBS: low
o ABG: metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the differentials?

A
  1. Sepsis/ TORCH
    Rule in:
    Vomiting, poor feeding
    Poor weight gain
    seizures
    Cataracts, Hepatosplenomegaly -
    TORCH
    Galactosemia patients are at
    increased risk for E. coli sepsis

Rule out:
(+) NBS: Galactosemia
jaundice WBC normal, Blood CS: NG

  1. IEM
    Rule in:
    Vomiting, poor feeding
    jaundice
    Poor weight gain
    seizures
    ABG: metabolic acidosis
    RBS: low

Rule out:
(+) NBS: Galactosemia

  1. GERD
    Rule in: Vomiting, poor feeding (+)
    Poor weight gain
    Severely wasted, severe
    stunted

Rule out:
NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly

4.GI malformations: (Atresia, pyloric stenosis)
Rule in:
Vomiting, poor feeding
Poor weight gain
Severely wasted, severe
stunted

Rule out:
(+) NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly
Babygram: Paucity of gas bowel
patterns

  1. RTA
    Rule in:
    Vomiting, poor feeding
    Poor weight gain
    Severely wasted, severe
    stunted
    ABG: metabolic acidosis

Rule out:
(+) NBS: Galactosemia
Jaundice, seizure
Cataracts, hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

work-up

A

o A positive (ie, abnormal) indication on the newborn
screen must be followed by a Direct enzyme assay
using erythrocytes which shows Deficient activity of
galactose-1-phosphate uridyl transferase
demonstrable in hemolysates of erythrocytes, which
also exhibit increased concentrations of galactose-1-
phosphate
Additional in work up for cases of FTT:
o Basic work-up may include CBC (for anemia), Blood
gas (RTA, metabolic disease), TFTs, UA
o (renal and metabolic disease), ESR/CRP (sign of
inflammation/infection), stool for fat, pH, reducing
o substances, occult blood, ova and parasites, sweat
chloride, lead, TB and HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment

A

Treatment:
o Early diagnosis and treatment have improved the
prognosis of galactosemia
o Elimination of galactose from the diet reverses growth
failure and renal and hepatic dysfunction.
o Various milk substitutes are available (casein
hydrolysates, soybean-based formula).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prognosis

A

Prognosis:
o Most patients with severe galactosemia who do not
receive treatment often do not survive the newborn
period. Even with appropriate dietary therapy, most
patients have at least 1-2 long-term complications
(ovarian failure with primary or secondary
amenorrhea, decreased bone mineral density,
developmental delay, and learning disabilities that
increase in severity with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acidic urine odor

A

Methylmalonic acidemia (methylmalonic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cabbage urine odor

A

hepatorenal tyrosinemia, methionine malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cat urine

A

3-methylcrotonyl CoA dehydrogenase deficiency, multiple carboxylase deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Maple syrup/burnt syrup

A

MSUD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mouse/musty

A

PKU (phenylacetate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

rancid butter

A

hepatorenal tyrosenemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sweaty feet

A

isovaleric acidemia, glutaric aciduria, Type II (Isovaleric acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical approach to a newborn infant with a suspected metabolic disorder

A

p. 178

  1. Clues in Hx:
    - Marriage is consanguineous, hx of recurrent abortion,
    hx of unexplained neonatal death in siblings especially
    assoc with acidosis, coma and convulsions, sibling
    diagnosed suffering an IEM
  2. Clues in PE
    - Tachypnea, apnea, lethargy
    - Hyper/hypotonicity
    - Hepatosplenomegaly, ambiguous genitalia, jaundice
    - Dysmorphic or coarse facial fx
    - Rashes/patchy hypopigmentation
    - Ocular (cataracts, lens dislocation, pigmentary
    retinopathy
    - Intracranial hemorrhage
    - Unusual odors
  3. Laboratory
    a. ABG – metabolic acidosis with inc anion
    gap, primary respiratory alkalosis
    b. Plasma ammonia elev
    c. Hgt – hypoglycemia
    d. Serum and urine ketones – ketosis and
    ketonuria
    e. TB, DB, IB, elev LFTs – hyperbilirubinemia
    f. Lactic acidosis
    g. High lactate/pyruvate ratio
    h. Non-glucose reducing substances in urine
    i. CBC – neutropenia, thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management

A

Mgt
1. Newborn screening - do after the 24th HOL or 48th-72nd HOL. If collected at <24h, repeat at 2 WOL
- In sick children, no later than 7d; NICU test by 7d-1 mo.
- For PT, ideal time should be at 5-7d old
- Prior to providing TPN, blood transfusion or on NPO
- Newborn screening act 2004 or Republic act 9288
o Provide an opportunity for every NB for early identification of conditions that can cause mental retardation or death

17
Q

What is the enzyme defect for congenital hypothyroidism?

A

multiple disorders
CM: appear normal at birth; large fontanelles, jaundice, macroglossia, hypotonic, lethargic, weak cry

18
Q

What is the enzyme defect in CAH?

A

21-hydroxylase deficiency
CM: salt wasting
simple virilizing

19
Q

What is the enzyme defect of phenylketonuria?

A

phenylalanine hydroxylase
PTPS
Normal at birth

20
Q

What is the enzyme defect in galactosemia?

A

Galactose 1 phosphate
Uridyl transferase
Galactokinase
Galactose-4 epimerase

CM: normal at birth, jaundice, feeding intolerance, FTT, hepatomegaly

21
Q

What is the enzyme defect in G6PD deficiency?

A

Glucose-6-phosphate dehydrogenase

CM: normal at birth; jaundice, pallor

22
Q

Golden period

A

CH: 2 weeks
enzyme screened: TSH
Confirmatory: TSH and T4 levels

CAH:
1-2 weeks
enzyme screened: 17-OHP
Confirmatory: 17-OHP quantitative levels

PKU:
2 weeks
enzyme: Phenylalanine
Confirmatory:phenylalanine/tyrosine

Gal: 3 weeeks
enzyme screened: GALT/Gal metabolites
confirmatory: enzyme measurement

G6PD deficiency:
enzyme: G6PD
confirmatory: quantitative enzyme measurement

23
Q

Factors that affect NBS result:

A
  • BT, dialysis, IV abx, PT, NPO since birth
24
Q

Differetials

A

DDx: G6PD deficiency (p.148)
Hypothyroidism (p.125)
Congenital adrenal hyperplasia (p.172)

25
Q

What is Galactosemia? Difference between Classical and non-classical?

A

GALACTOSEMIA
- Classical: deficiency of galactose-1-phosphate uridyl
transferase

  • Non-classical: deficiency in galactokinase or epimerase
  • Autosomal recessive
26
Q

What are the clinical manifestations of galactosemia?

A

CM
1. vomiting, jaundice, hepatomegaly, anorexia and FTT
2. sepsis with E.coli
3. lenticular cataract formation
4. MR, pseudotumor cerebri
5. F: ovarian failure
6. Delayed speech and language

27
Q

Management of Galactosemia

A

Mgt
1. Exclusion of galactose in diet
2. Substitution of casein hydrosylate or soybean
preparation

28
Q

What is Phenylketonuria?

A

PHENYLKETONURIA
- Classical: lack on enzyme phenylalanine hydroxylase
- PTPS deficiency: lack of co-enzyme 6-pyruvoyltetrahydropterin
synthase or tetrahydrobiopterin
- Hyperphenylalaninemia

29
Q

Clinical manifestations of Phenylketonuria?

A

CM
1. N at birth
2. MR (1/3 of pxs)
3. Cerebral palsy (1/3)
4. Mild neurologic signs (1/3)

30
Q

Management of PKU?

A

Mgt
1. Dietary – giving special milk formula (phenyl-free)
2. Limiting natural protein intake
3. BH4
4. Levodopa
5. 5-HT or serotonin

31
Q

What is MSUD?

A

MAPLE SYRUP URINE DISEASE
- Caused by a defect in the branch chain oxoacid
dehydrogenase multienzyme complex

32
Q

What are the different phenotypes of PKU?

A
  1. Classic
    Age of onset: neonatal
    CM: maple syrup odor of cerumen, poor feeding, irritability, lethargy, focal dystonia, fencing, “bicycling”
    -elevated BCAAs in plasma
    -Elevated plasma allo-isoleucine
    -elevated BCKAs
    -positive urine DNPH test
    -Ketonuria
  2. Intermediate
    age of onset: variable
    CM: maple syrup odor of cerumen; poor growth, poor feeding, irritability, developmental delays, encephalopathy during illness
    -similar to classic phenotype though quantitatively less severe
  3. Intermittent
    age of onset: variable
    CM: normal early growth and development; episodic decompensations that can be severe
    -normal BCAAs when well
    -similar to classic biochemical profile during illness
  4. Thiamine-responsive
    age of onset: variable
    CM: similar to the intermediate phenotype
33
Q

MSUD manifestations

A
  1. 12-24 HOL: maple syrup odor in cerumen, increase in
    BCAA levels and allo-isoleucin
  2. 2-3 DOL: ketonuria, irritability, poor feeding
  3. 4-5 DOL: lethargy, opisthotonos, stereotypical movts
  4. 7-10d: coma, respiratory failure
34
Q

management

A

Mgt
1. Dietary management
a. Leucine restriction
b. Supplement with isoleucine and valine

35
Q

EXPANDED NEWBORN SCREENING

A

Screen for >28 (35) total IEM disorders
o Endocrine disorders – severe MR, death
o Amino acid disorders – MR, coma, death
from metabolic crisis
o FA disorders – devtl and physical delays,
neuro impairment, sudden death, coma, sz,
cardiomegaly, hepatomegaly, ms weakness
o Organic acid disorders – devtl delay, RD,
neuro damage, sz, coma, early death
o Urea cycle defect – sz, MR, death
o Hemoglobinopathies – alpha thalassemia,
sickle cell ds
§ Painful crises, anemia, stroke, MOF, death
§ NOT beta thal bec physiologic shift of Hgb to adult levels at 6MOL
o Others – cystic fibrosis